Breast Cancer Trials16 Mai 2023

Can We Improve Breast Cancer Treatment With Fewer Side Effects?

Can We Improve Breast Cancer Treatment with Fewer Side Effects?

As part of the Breast Cancer Trials clinical fellowship program, Dr Adam Ofri is working on two research projects focusing on the de-escalation of treatment. His first study, called the ‘Targeted Axillary Dissection Based Study’, aims to evaluate the armpit nodes after chemotherapy, in the hopes that fewer nodes will need to be removed during surgery, whilst still providing the same control of cancer in the armpit area.

His second study, called the ‘Decision RT Based Study’ focuses on Decision RT which is a test that is being developed to examine breast tissue from patients with DCIS to measure the benefit they would receive from radiotherapy, in the hopes of potentially avoiding patients receiving unnecessary radiotherapy. Find out more in our latest podcast episode.

Like this episode? ⁠⁠Follow Breast Cancer Trials on Social Media:

Guest: Dr Adam Ofri

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about clinical trials research.

Find out more: www.breastcancertrials.org.au

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(168)

Oncoplastic Breast Surgery: Balancing Cancer Treatment and Aesthetic Outcomes

How can breast cancer surgery achieve the best cancer outcomes while also considering the appearance and shape of the breast? In this episode, we sit down with Professor Elisabeth Elder to explore onc...

13 Okt 10min

Hot Flushes, Poor Sleep & More: Managing Menopause After Breast Cancer

Breast cancer treatment can bring on menopause suddenly or make existing symptoms more severe, significantly affecting a woman's quality of life. In this episode, we sit down with Dr Christina Jang to...

30 Sep 7min

What's Next When Treatment for Triple-Negative Breast Cancer Stops Working?

Treatment for triple-negative breast cancer has advanced significantly, but challenges remain when, in some cases, the disease returns after treatment.In this episode, we sit down with Dr Belinda Yeo ...

18 Sep 8min

What Makes Lobular Breast Cancer Different? Unlocking the Biology of Invasive Lobular Carcinoma

Invasive lobular carcinoma is the second most common type of breast cancer, yet there is still much to learn about what makes this disease biologically distinct. In this episode, we sit down with Asso...

8 Sep 5min

Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical Trial

Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical TrialCould skipping radiation after breast-conserving surgery be safe for some patient...

6 Feb 6min

Neoadjuvant Now: What's Next in Pre-Surgical Breast Cancer Treatment?

Neoadjuvant Now: What's Next in Pre-Surgical Breast Cancer Treatment?More and more breast cancer patients are now receiving treatment before surgery - but what’s next for this approach? In this episod...

7 Nov 20259min

Next Gen Oncology: Insights for Trainees and Early-Career Clinicians

Next Gen Oncology: Insights for Trainees and Early-Career CliniciansAre you a trainee or early career professional in oncology looking to connect, learn, and grow? In this episode, we highlight the Tr...

6 Nov 20258min

Caring for the Caregivers: Preventing Burnout in Oncology

Caring for the Caregivers: Preventing Burnout in OncologyWhat happens when the people caring for everyone else are running on empty? In this episode, we sit down with London-based Professor of psycho-...

6 Nov 202521min